Choosing an ibogaine clinic is not like choosing a hospital for a routine procedure, and it should not be approached the same way.
Ibogaine is not an approved medicine anywhere. That means no regulator inspects ibogaine clinics against an ibogaine standard, no licensing body certifies them, and no professional register can be checked. Legality tells you a provider may operate. It tells you nothing about whether it is competent.
The consequence is a field where excellent hospital-based programmes and operations that should not be treating anyone exist side by side, marketed in almost identical language. This guide is about telling them apart.
Why this choice carries unusual weight
In most medical decisions, the main variable is quality of outcome. Here the main variable is safety.
Ibogaine’s principal risk is cardiac, and it is largely manageable — but only through measures that cost money and generate no revenue: screening people out, staffing a physician through a ten-hour session, monitoring for 24 to 48 hours afterwards. A provider under commercial pressure can remove all of those and still appear, from a website, to be offering the same treatment.
This is why the overwhelming majority of ibogaine-associated deaths have occurred in unsupervised or lightly supervised settings rather than in medical ones. The compound was broadly the same. The context was not.
The four non-negotiables
Everything else is preference. These four are not.
- Cardiac and blood screening before acceptance. An ECG and blood work — including electrolytes, liver enzymes and kidney function — reviewed by a physician before treatment is agreed, not on the day of arrival. A provider who will treat you without seeing test results is not screening; it is processing.
- A physician physically present throughout the session. Not on call. Not reachable. Present.
- Continuous monitoring for 24 to 48 hours. Cardiac effects do not end when the psychological experience does.
- A real emergency plan. What equipment is on site, and how far is the nearest intensive care unit? In São Paulo state, Brazil, the state’s drug-policy council has recommended since 2016 that ibogaine treatment take place in a hospital, precisely because that is where the capacity to respond exists.
If any one of these is missing or answered vaguely, nothing else about the programme matters.
Types of provider
The word “clinic” covers very different things. Four broad categories are worth distinguishing.
Hospital-based programmes. Treatment delivered inside a licensed hospital with full medical infrastructure. The highest safety ceiling, and generally the least comfortable surroundings — a hospital room is a hospital room.
Licensed medical clinics. Dedicated facilities with physicians, nursing staff and monitoring equipment, typically more comfortable than a hospital. Quality varies most widely in this category, which makes verification most important here.
Residential recovery programmes. Longer stays combining treatment with therapy and structured recovery time, in a residential rather than clinical setting. The medical component is what needs checking.
Retreats. Ceremonial or wellness-oriented, sometimes without meaningful medical oversight. For a compound with ibogaine’s cardiac profile, we do not consider this an appropriate setting, and we do not work with providers in this category.
None of the first three is automatically right. A medically complex case belongs in a hospital; someone in good health seeking deeper psychological work may be better served by a longer residential programme. The mistake is choosing on atmosphere.
What separates good from merely adequate
Once the non-negotiables are satisfied, four things distinguish the better programmes.
Screening rigour — measured by rejections. Ask what proportion of applicants a clinic declines. In well-run hospital programmes, a significant share of applicants are found unsuitable and turned away. A provider that accepts nearly everyone who can pay is describing its screening more clearly than any brochure could.
Psychotherapy as part of the treatment. In the programme behind the published Brazilian research, ibogaine is treated as a facilitator of psychotherapy rather than the treatment itself — roughly four sessions before and four after — and patients unwilling to engage in that work are not accepted at all. A programme offering the session without the psychological work is offering the smaller half.
Structured aftercare. Relapse risk is highest in the weeks and months following treatment. Ask what specifically happens after discharge, and for how long.
Follow-up data. A clinic that genuinely follows its patients knows roughly what proportion relapse. One that has no idea is not following up — which also means it cannot learn from its own outcomes.
Red flags
Any one of these justifies walking away.
- No ECG or blood tests required, or “we’ll do it when you arrive” as the only screening
- Guaranteed results, or claimed success rates above 90% — inconsistent with any published data on addiction treatment
- Pressure to book quickly, deposit urgency, or discounts that expire
- Vagueness about who administers treatment and what their qualifications are
- No named physician anywhere on the website
- Reluctance to discuss risks, or describing ibogaine as “completely safe” or “natural and therefore gentle”
- No aftercare, or aftercare that means a phone call
- Refusal to answer how many applicants they decline
- Treatment offered in a hotel, private home or unnamed “villa” rather than a medical facility
- Willingness to treat you despite a condition on their own contraindication list
That last one is the most serious of all. A provider that bends its own medical rules for you is not doing you a favour.
How to verify what you are told
Marketing claims are easy to make. Four checks are worth doing on any shortlist.
Check the named physician independently. A real doctor has a real registration number in their country’s medical register — Dr. Bruno Rasmussen, for instance, holds CRM 49871 in Brazil. If a clinic names no physician, or names one you cannot verify, treat that as the answer.
Ask for the published evidence behind any claim. If a clinic cites research, ask which study. Peer-reviewed work has authors, a journal and a DOI.
Request the screening protocol in writing before paying anything. Which tests, reviewed by whom, and what would disqualify you. A serious programme has this documented; a marketing operation improvises it.
Read reviews for the right thing. Testimonials about beautiful surroundings and kind staff tell you little. What matters is whether anyone describes the medical process — screening, monitoring, what happened when something went wrong.
Ibogaine research and evidence →
What price tells you — and what it doesn't
Ibogaine programmes range from roughly $6,500 to over $53,000, and price maps onto two very different things.
Above a certain floor, additional cost usually buys comfort: private villas, longer stays, more individual attention. That is a legitimate preference and has little to do with clinical safety.
Below that floor, cost cuts come out of the medical side — because screening, physician cover and monitoring hours are the largest expenses in a properly run programme. A quote far under the market range should prompt one question: which of the four non-negotiables was removed to reach it?
How we can help
Everything above is doable alone. It is also a great deal of work, conducted in an unregulated market, at a moment when you or someone you love is in crisis — which is precisely when people make decisions they would not otherwise make.
That is the gap we exist to fill. Rehab Global does not own clinics. We can help you ask these questions and compare the answers.
You are welcome to use this guide and choose entirely without us. If you would rather not do it alone, that is what we are for.
Free and confidential. No obligation, and no cost to you — you pay the clinic directly at its own price.